- decreased circulating HDL cholesterol level / IMPC
- increased leukocyte cell number / IMPC
- abnormal femur morphology / IMPC
- decreased circulating cholesterol level / IMPC
- decreased circulating glucose level / IMPC
- increased mean corpuscular hemoglobin / IMPC
- preweaning lethality, incomplete penetrance / IMPC
C57BL/6N-Atm1Brd Slc38a2tm1a(KOMP)Wtsi/WtsiPh
Status | Available to order |
EMMA ID | EM:09889 |
International strain name | C57BL/6N-Atm1Brd Slc38a2tm1a(KOMP)Wtsi/WtsiPh |
Alternative name | EPD0860_4_G06 |
Strain type | Targeted Mutant Strains |
Allele/Transgene symbol | Slc38a2tm1a(KOMP)Wtsi |
Gene/Transgene symbol | Slc38a2 |
Disclaimer | Please note that for EUCOMM and KOMP-CSD mice supplied to the scientific community by INFRAFRONTIER/EMMA:
|
Information from provider
Provider | Wellcome Trust Sanger Institute |
Provider affiliation | Wellcome Trust Sanger Institute |
Genetic information | This mouse line originates from KOMP ES clone EPD0860_4_G06. For further details on the construction of this clone see the page at the IMPC portal. |
Phenotypic information | Potential phenotyping data in the IMPC portal |
References | None available |
Information from EMMA
Archiving centre | Institute of Molecular Genetics, Prague, Czech Republic |
Disease and phenotype information
IMPC phenotypes (allele matching)
IMPC phenotypes (gene matching)
- preweaning lethality, incomplete penetrance / IMPC
- increased mean corpuscular hemoglobin / IMPC
- decreased circulating glucose level / IMPC
- decreased circulating cholesterol level / IMPC
- abnormal femur morphology / IMPC
- decreased circulating HDL cholesterol level / IMPC
- increased leukocyte cell number / IMPC
Information on how we integrate external resources can be found here
INFRAFRONTIER® and European Mouse Mutant Archive - EMMA® are registered trademarks at the European Union Intellectual Property Office (EUIPO).